Can cannabis help with opioid addiction treatment?
Part of Mental health, Pain clinical trials.
This trial tests if adding a specific cannabis product to standard methadone treatment helps people with opioid use disorder. It's for adults over 25 who recently started methadone and have used cannabis before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 25 years old
- You have been diagnosed with opioid use disorder
- You started or restarted methadone treatment in the last 30 days
- You have used cannabis in the past 6 months
- You agree to use only the cannabis provided by the study and not use any other cannabis or related products
- You are willing to avoid driving or operating machinery for at least 10 hours after taking the study medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two cannabis-based medicines, dronabinol and Epidiolex, can help ease withdrawal symptoms or cravings in people who have just started buprenorphine for opioid use disorder. It may be a good fit if you are early in treatment and still have symptoms or slip-ups.
This study tests whether a combination of THC and CBD can help people who have both opioid use disorder and chronic low back pain. You would need to be on a stable dose of methadone and have used cannabis at least once in your life.
This study tests whether cannabis can help people with opioid withdrawal and reduce opioid use. You will stay in a research center and receive cannabis in a controlled setting while researchers monitor your symptoms.
This Phase 1 trial studies cannabis in people with opioid use disorder. The goal is to better understand how it may affect opioid use disorder, while monitoring safety.
This Phase 1 study tests how adding psilocybin to a standard opioid treatment (buprenorphine-naloxone) affects recovery and symptoms in people with moderate-to-severe opioid use disorder. It may help researchers understand whether this combination is safe and beneficial alongside medication for opioid withdrawal and cravings.
This early study tests whether CBD can reduce symptoms of chronic pain in people receiving opioid maintenance treatment for opioid use disorder. It also looks at safety and whether CBD can be added without causing major problems.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.